$ACHV 8-K SEC Filings

Filed On	Filing
01 Oct 2026	8-K: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers On October 1, 2026, Achieve Life Sciences, Inc. (the “Company”) announced that the Board of Directors of the Company (the “Board”) appointed Benjamin Halladay as the Company’s Chief Financial Officer and “principal financial officer,” ef...
14 Aug 2026	8-K: Other Events
11 Aug 2026	8-K: Results of Operations and Financial Condition
06 Jul 2026	8-K: Amendments to Articles/Bylaws; Change in Fiscal Year; Submission of Matters to a Vote of Security Holders
02 Jun 2026	8-K: Departure/Election of Directors or Officers; Compensation
12 May 2026	8-K: Results of Operations and Financial Condition; Departure/Election of Directors or Officers; Compensation
16 Apr 2026	8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities +2 more
24 Mar 2026	8-K: Results of Operations and Financial Condition
06 Nov 2025	8-K: Results of Operations and Financial Condition
07 Oct 2025	8-K: Departure/Election of Directors or Officers; Compensation
11 Sep 2025	8-K: Departure/Election of Directors or Officers; Compensation
07 Aug 2025	8-K: Results of Operations and Financial Condition
27 Jun 2025	8-K: Entry into a Material Definitive Agreement; Other Events
06 Jun 2025	8-K: Submission of Matters to a Vote of Security Holders
13 May 2025	8-K: Results of Operations and Financial Condition
11 Mar 2025	8-K: Results of Operations and Financial Condition
10 Feb 2025	8-K: Other Events
10 Jan 2025	8-K: Departure/Election of Directors or Officers; Compensation
09 Dec 2024	8-K: Departure/Election of Directors or Officers; Compensation
07 Nov 2024	8-K: Results of Operations and Financial Condition

Comments